|
|
||||||||
From the Department of Ophthalmology, the University of Sydney (Center for Vision Research, Westmead Millennium Institute), Australia.
| Abstract |
|---|
|
|
|---|
METHODS. This was a population-based, cross-sectional study comprising 3654 participants (82.4% response) aged 49+ years from the Blue Mountains region of Australia. Retinal arteriolar and venular diameters were measured from digital retinal images, using a standardized method, and were summarized as central retinal arteriolar (CRAE) and central retinal venular (CRVE) equivalents.
RESULTS. After adjustment for venular diameter, regression plots, and regression coefficients from linear models demonstrated an inverse relationship between arteriolar diameters and mean arterial BP (MABP) in all age groupsgreatest in the <60 age group and progressively diminishing thereafter. Increasing age was associated with greater arteriolar narrowing (of lesser magnitude), in each MABP category (<100, 100109, 109129, and >120 mm Hg) with the greatest effect in persons with MABP <100. There was evidence of interaction between age and blood pressure in their effects on arteriolar diameter (P = 0.003). After adjustment for arteriolar diameter, age was inversely associated with venular diameter (the effect was progressively greater for persons with progressively higher MABP), and MABP was positively associated with venular diameter in subjects aged <80 years (interaction P = 0.05).
CONCLUSIONS. These findings demonstrate the importance of elevated blood pressure in arteriolar narrowing, especially in those younger than 60 years and show that venules tend to widen rather than narrow with increasing blood pressure levels.
To our knowledge, no studies have evaluated the separate effects of age and blood pressure on retinal arteriolar or venular diameters, after considering the shared variance between arterioles and venules. In this study, we explored the separate effects of age and mean arterial blood pressure (MABP) on retinal vessel diameter, after stratifying for both MABP and age, as well as adjusting for shared variance between the two vessel diameters, in the Blue Mountains Eye Study baseline population.
| Methods |
|---|
|
|
|---|
A standardized interview and examination was performed on all participants over the period 1992 to 1994. Information on demographic variables was gathered from the questionnaire. Questions were asked regarding lifestyle factors, including smoking. Participants were asked for details of current and past smoking, including the type (manufactured or hand-rolled cigarettes, cigars, or pipe tobacco), usual amount (current and past), time of commencement, and, where applicable, time of quitting. Current smokers were defined as participants who smoked cigarettes, cigars, or a pipe regularly, and had given up smoking for less than 12 months before the examinations, whereas past smokers were defined as participants who had ever smoked cigarettes, cigars, or a pipe regularly, but had ceased smoking for at least 12 months before the examinations. A single measure of resting, seated systolic and diastolic blood pressure by mercury sphygmomanometer was recorded from the first and fifth Korotkoff sounds. MABP was defined as 0.33 x systolic blood pressure + 0.67 x diastolic blood pressure. Body-mass index was calculated as weight (in kilograms)/height (in meters).2 Fasting blood samples were taken and processed for serum glucose. Blood samples were analyzed at the Institute of Clinical Pathology and Medical Research, Westmead Hospital.
Stereoscopic retinal photographs (30°) of the macula and other retinal fields of both eyes with a fundus camera (model FF3; Carl Zeiss Meditec GmbH, Oberkochen, Germany), were taken at baseline. Detailed grading methods have been described previously.1 In brief, we used a computer-assisted method, developed at the University of Wisconsin-Madison,9 to measure the internal diameter of retinal arterioles and venules from all gradable digitized photographs, which were then summarized using formulas by Parr and Hubbard.6 9 10 The formulas take into account branching patterns of arterioles and allow individual vessel diameters to be combined into the summary indices, central retinal arteriolar (CRAE) and central retinal venular (CRVE) equivalents, reflecting the mean arteriolar and venular diameters, respectively, of that eye.
Statistical Analysis
Statistical analyses were performed with commercial software (Statistics Analysis System ver. 8.2; SAS Institute, Cary, NC). To assess the effect of blood pressure or age on retinal arteriolar or venular diameter, independent of the fellow vessel component, we used venule-adjusted CRAE and arteriole-adjusted CRVE, calculated using the residual method initially described by Willet,11 which controls for the shared variance between the two diameter variables. Venule adjusted arteriolar diameter was defined by using linear regression with venular diameter as the independent variable and arteriolar diameter as the dependent variable, obtaining the residuals, and adding them to an expected mean venular diameter, given the size of arterioles. Similarly, arteriole adjusted venular diameter was defined using regression of arteriolar diameter as the independent variable and venular diameter as the dependent variable, with the residuals from the regression added to the expected mean arteriolar diameter. This method has been widely used in nutritional epidemiologic research. The resultant adjusted variables, arteriole-adjusted CRVE and venule-adjusted CRAE, can be considered to represent the nonshared variance of each vessel diameter, respectively.
Regression graphs were generated that displayed the linear relationship between MABP and venule adjusted CRAE or arteriole adjusted CRVE by four age groups: <60 years, 60 to 69 years, 70 to 79 years, and
80 years. The slope of each line demonstrates the effect of MABP on arteriolar diameter and qualitatively the "gap" between the age group lines demonstrates the effect of age. Mean venule adjusted CRAE and arteriole adjusted CRVE were obtained using analysis of covariance (ANCOVA), stratified by age and MABP groups. Linear trends and regression coefficients for the changes in mean venule adjusted CRAE or mean arteriole adjusted CRVE (dependent variable) associated with increasing age stratified by MABP category, or the changes associated with elevated BP stratified by age group, were obtained. In these linear regression models, we included age (per decade, in models for MABP subgroups) or MABP (per 10 mm Hg, in models for age subgroups), and gender, body mass index, smoking status, and serum levels of glucose, as independent variables. Interactions between age and MABP were examined qualitatively and tested in the multiple linear regression models.
| Results |
|---|
|
|
|---|
80 years was 984 (29.3%), 1239 (36.9%), 864 (25.8%), and 268 (8.0%), respectively. The mean MABP for corresponding age groups was 101.7, 104.0, 105.9, and 106.3 mm Hg, respectively. Figures 1 and 2 illustrate the relationship between venule adjusted mean CRAE, arteriole adjusted mean CRVE, and MABP, stratified by four age groups. Figure 1 shows that each consecutively older age group had successively smaller mean arteriolar diameters when MABP was within the normal range (<100 mm Hg), and within each age group, there was arteriolar diameter narrowing with increasing levels of MABP. There is a greater effect of MABP on arteriolar diameter in the younger age groups, indicated by the greater slope of decline in the younger age groups than in the oldest group. This finding is supported by the data presented in Table 1 , which shows mean adjusted CRAE and regression coefficients stratified by age group and the category of MABP. The regression coefficient of 2.3 per decade of age in persons with MABP < 100 represents a 2.3-µm reduction in mean venule adjusted CRAE for each decade increase in age. There is a progressive reduction in the absolute value of regression coefficients for the effect of MABP on CRAE in consecutively older age groups and smaller regression coefficients for the effect of increasing age on CRAE in the higher MABP categories than in persons whose MABP was within the normal range. The linear trends for change in arteriolar diameter associated with increasing MABP were significant in the three younger age groups, and the trend for change in arteriolar diameter associated with increasing age was significant only in those who were normotensive (MABP < 100 mm Hg). The qualitative impression of interaction between age and MABP on arteriolar diameter taken from Figure 1 and Table 1 was verified statistically (P = 0.003).
|
|
|
|
|
|
| Discussion |
|---|
|
|
|---|
To our knowledge, previous studies have not accounted for the shared variance between arteriolar and venular diameters, when evaluating the association between either arteriolar or venular diameter and age or blood pressure. Biologically, persons with smaller arterioles are naturally more likely to have smaller venules, which may be explained by body size or a commonality of genetic determinants between venules and arterioles within the same individual. This explains the considerable correlation between arteriolar diameter, CRAE, and venular diameter, CRVE (correlation coefficient, r = 0.59). The arteriolar-to-venular ratio (AVR) was initially used to account for this correlation, but was misinterpreted as representing changes in arteriolar diameter5 9 by assuming stable venular diameter. When including the correlated fellow vessel component in multivariate models (CRVE when CRAE is the dependent variable, and vice versa), the variation of CRAE explained by the resultant model is more than doubled, from <20% to >40%. Using the residual method to adjust for the fellow vessel component, we are able to eliminate the shared variance and thus assess associations with each vessel type independently. The potential confounding effect from the correlated fellow vessel component has been documented previously.12 13 The adjusted vessel diameter variables would permit an assessment of the effects of age and blood pressure on vessel diameter changes that was independent of the effect from the fellow component, while accounting for factors shared by the two retinal vessel diameter components, including the effects of body size and genetic determination.
However, there are some concerns about using this method and interpreting the adjusted variables. The adjusted vessel diameter variables should not be considered equivalent to the unadjusted diameter variables. We may have overadjusted for the shared factors, or there may be the possibility of masking or exaggerating the associations assessed. For example, it may be possible that the observed widening of arteriole adjusted venular diameter with increasing blood pressure represents the relative difference from arterioles, which narrow with increasing blood pressure, rather than an absolute change in venular diameter itself. Although there are biologically plausible links between widening venular diameter and elevated BP, as outlined in the next paragraph, the interpretation of these findings should be undertaken with these possibilities borne in mind.
In this study, analyses using unadjusted arteriolar diameter showed that age and blood pressure had a similar magnitude and direction of effect on arteriolar diameter narrowing, whereas after adjustment for venular diameter, blood pressure had a greater effect on arteriolar diameter than did age, though the direction of the effect remained the same. In contrast, analyses using unadjusted venular diameter showed that higher blood pressure was negatively associated with venular narrowing, whereas after adjustment for arteriolar diameter, blood pressure was positively associated with venular widening. This finding contrasts with previously reported cross-sectional analytic results2 6 of increasing blood pressure associated with narrower venular diameters and a longitudinal association between venular narrowing and incident hypertension.12 Nevertheless, we believe that our study findings with analyses that coadjusted for vessel diameters avoid the potential confounding effect from the fellow vessel component13 14 and are consistent with existing evidence. In the case of arteriolar diameter, it is consistent with existing knowledge, and the interaction found between blood pressure and age is biologically plausible. In the case of venular diameter, it replicates our recently reported data on the association between venular widening and incident hypertension.13 Such an association is also biologically plausible, as inflammatory processes and/or damage to vascular endothelium are likely contributors to the pathogenetic link between wider venular diameter and elevated blood pressure. Wider venular diameter has been shown to be associated with inflammatory factors such as C-reactive protein, interleukin-6, amyloid-A levels, and markers of endothelial dysfunction,15 and accumulated evidence also points to an inflammatory pathogenesis for hypertension.16
We have shown that higher blood pressure is associated with greater retinal arteriolar diameter decline compared with age across all age groups, albeit with a decreasing magnitude in older persons. This finding underscores the importance of regulating elevated blood pressure in all age groups. In addition, the implication of effect of increasing age on arteriolar diameter in persons who are normotensive deserves discussion. Current research is focused on identifying the differences between changes due to "normal" aging and those due to pathologic processes associated with age, as well as identifying biomarkers that distinguish between age-dependent diseases and "normal" aging. In terms of cardiovascular disease, age has traditionally been considered a dominant, nonmodifiable risk factor. A review by Najjar et al.17 showed that normal ageing is accompanied by a number of structural and functional changes in the cardiovascular system. Luminal dilatation of elastic arteries, increased arterial wall thickening and endothelial dysfunction are some of the changes described. The authors suggest that these changes observed in subjects with cardiovascular disease are similar to aging changes but occur at earlier ages. Our results showing a greater effect of aging on arteriolar diameter among normotensive subjects and a greater effect of elevated blood pressure in younger persons compared with older persons, suggest that hypertension accelerates aging-related arteriolar changes.
The current analyses demonstrated statistically significant narrowing of venules associated with age, independent of retinal arteriolar diameter. Though this has been reported in previous studies,2 6 the reason for this finding has not been explained. A pathologic study has described age-related anatomic changes in the human renal veins.18 It found that though the muscle fiber bundles atrophied with age, the elastic fiber bundles hypertrophied. Hypertrophy of elastic fibers may be a mechanism for the venular narrowing with age, found in our study. Conversely, age-related narrowing of retinal vessels, including arterioles and venules, demonstrated in our findings, may be a vascular phenomenon or due to loss of retinal neurons associated with older age. Previous experimental studies have shown age-dependent reductions in ocular (both choroidal and retinal) blood flow.19 20 Other studies have also shown that there is a loss of ganglion cells and their axons, photoreceptors, and retinal pigment epithelial cells in the retina associated with age.21 22 23 Such depletion of nerve fiber numbers could reduce ocular perfusion requirements, thus leading to the vessel narrowing observed. We are unable, however, to explain our findings of a stronger effect of age on venular diameter narrowing as blood pressure increases.
In summary, we used a novel method that accounts for correlation between arterioles and venules and also for variation in vessel diameter associated with body size or genetic factors, to explore the relationship between retinal arterioles, venules, and age or blood pressure. Our findings demonstrate an interaction between age and blood pressure on these small vessel diameters, and emphasize the importance of elevated blood pressure to arteriolar narrowing, especially in those younger than 60 years. We have also shown that venules widen rather than narrow with increased blood pressure. The effect of age on vessel diameter could be considered to be related not only to biological aging but also to age-related conditions other than elevated blood pressure. These findings, if confirmed in future studies, may have clinical implications in cardiovascular disease prevention and in studies of healthy aging.
| Footnotes |
|---|
Submitted for publication August 1, 2006; revised September 13, 2006; accepted November 23, 2006.
Disclosure: S. Kaushik, None; A. Kifley, None; P. Mitchell, None; J.J. Wang, None
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked "advertisement" in accordance with 18 U.S.C.
1734 solely to indicate this fact.
Corresponding author: Jie Jin Wang, University of Sydney, Department of Ophthalmology, Center for Vision Research, Westmead Millennium Institute, Westmead Hospital, Hawkesbury Rd, Westmead, NSW Australia, 2145; jiejin_wang{at}wmi.usyd.edu.au.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
J. J. Wang, E. Rochtchina, G. Liew, A. G. Tan, T. Y. Wong, S. R. Leeder, W. Smith, A. Shankar, and P. Mitchell The Long-term Relation among Retinal Arteriolar Narrowing, Blood Pressure, and Incident Severe Hypertension Am. J. Epidemiol., July 1, 2008; 168(1): 80 - 88. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Sun, G. Liew, J. J. Wang, P. Mitchell, S. M. Saw, T. Aung, E. S. Tai, and T. Y. Wong Retinal Vascular Caliber, Blood Pressure, and Cardiovascular Risk Factors in an Asian Population: The Singapore Malay Eye Study Invest. Ophthalmol. Vis. Sci., May 1, 2008; 49(5): 1784 - 1790. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kifley, G. Liew, J. J. Wang, S. Kaushik, W. Smith, T. Y. Wong, and P. Mitchell Long-term Effects of Smoking on Retinal Microvascular Caliber Am. J. Epidemiol., December 1, 2007; 166(11): 1288 - 1297. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |